ROTHSCHILD & CO ASSET MANAGEMENT US INC. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROTHSCHILD & CO ASSET MANAGEMENT US INC. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$17,417,000
-17.8%
734,267
-4.8%
0.18%
-21.0%
Q3 2019$21,186,000
-18.1%
770,962
-1.4%
0.23%
-17.0%
Q2 2019$25,874,000
-13.0%
781,926
-7.9%
0.28%
-13.5%
Q1 2019$29,742,000
+5.1%
848,799
-0.3%
0.32%
-6.5%
Q4 2018$28,286,000
-32.8%
851,483
+1.8%
0.34%
-21.1%
Q3 2018$42,094,000
-17.9%
836,028
-2.5%
0.43%
-21.6%
Q2 2018$51,299,000
+3.7%
857,120
-20.6%
0.55%
+0.2%
Q1 2018$49,454,000
+14.1%
1,079,788
-0.7%
0.55%
+20.4%
Q4 2017$43,333,000
-3.9%
1,087,415
-3.5%
0.46%
-7.9%
Q3 2017$45,089,000
-10.8%
1,127,218
-3.9%
0.50%
-13.1%
Q2 2017$50,550,000
+42.9%
1,172,865
+3.8%
0.57%
+40.6%
Q1 2017$35,365,000
+28.0%
1,129,858
+3.3%
0.41%
+15.7%
Q4 2016$27,620,000
+18.1%
1,093,877
+15.7%
0.35%
-12.5%
Q3 2016$23,379,000
+28.6%
945,357
+5.9%
0.40%
+22.3%
Q2 2016$18,181,000
+52.4%
892,551
+14.1%
0.33%
+46.4%
Q1 2016$11,929,000
+33.7%
782,231
+17.9%
0.22%
+38.3%
Q4 2015$8,921,000
+7.6%
663,749
+12.3%
0.16%0.0%
Q3 2015$8,289,000
+26.2%
590,829
+52.7%
0.16%
+33.9%
Q2 2015$6,570,000386,9540.12%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders